Quantitative proteomics identifies secreted diagnostic biomarkers as well as tumor-dependent prognostic targets for clear cell Renal Cell Carcinoma
A. Senturk, A. T. Sahin, A. Armutlu, M. C. Kiremit, O. Acar, S. Erdem, S. Bagbudar, T. Esen, N. Tuncbag, N. Ozlu
The paper uses quantitative proteomics to identify secreted biomarkers and prognostic targets in ccRCC, finding SPARC as a promising diagnostic marker and proposing a biomarker panel for prognosis.
bioRxiv · Feb 8, 2021Cancer Biology